Carcinoma of Unknown Primary Clinical Trials

• Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin
  ClinicalTrials.gov Identifier: NCT00022178 - Active, not recruiting
  squamous cell carcinoma of unknown primary; newly diagnosed carcinoma of unknown primary; undifferentiated carcinoma of unknown primary; ...
  
• Gemcitabine and Irinotecan in Treating Patients With Cancer of Unknown Primary
  ClinicalTrials.gov Identifier: NCT00066781 - Active, not recruiting
  adenocarcinoma of unknown primary; newly diagnosed carcinoma of unknown primary; squamous cell carcinoma of unknown primary; ...
  
• Gemcitabine, Docetaxel, and Capecitabine in Treating Patients with Cancer of Unknown Primary Origin
  ClinicalTrials.gov Identifier: NCT00119314 - Active, not recruiting
  newly diagnosed carcinoma of unknown primary; recurrent carcinoma of unknown primary
  
• Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin
  ClinicalTrials.gov Identifier: NCT00003558 - Active, not recruiting
  adenocarcinoma of unknown primary; newly diagnosed carcinoma of unknown primary
  
• Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor
  ClinicalTrials.gov Identifier: NCT00047125 - Active, not recruiting
  newly diagnosed carcinoma of unknown primary; squamous cell carcinoma of unknown primary
  
• Antineoplaston Therapy in Treating Patients With Cancer of Unknown Primary Origin
  ClinicalTrials.gov Identifier: NCT00003526 - Recruiting
  adenocarcinoma of unknown primary; recurrent carcinoma of unknown primary
  
• Bevacizumab and Erlotinib in the Treatment of Patients With Carcinoma of Unknown Primary Site
  ClinicalTrials.gov Identifier: NCT00193622 - Active, not recruiting
  Neoplasms, Unknown Primary
  
• Gemcitabine in Treating Patients With Metastatic Cancer of Unknown Primary
  ClinicalTrials.gov Identifier: NCT00357630 - Active, not recruiting
  Carcinoma of Unknown Primary; Pain
  
• The Final Diagnosis and Treatment Result of Metastatic Cervical Carcinoma of Unknown Primary
  ClinicalTrials.gov Identifier: NCT00302588 - Recruiting
  Metastasis Cervical Lymph Nodes of Unknown Primary Carcinoma
  
• Paclitaxel/Carboplatin Plus Bevacizumab/Erlotinib in the First Line Treatment of Carcinoma of Unknown Primary Site
  ClinicalTrials.gov Identifier: NCT00360360 - Recruiting
  Neoplasm, Unknown Primary
  
• Oxaliplatin and Capecitabine in the Treatment of Relapsed/Refractory Carcinoma of Unknown Primary Site
  ClinicalTrials.gov Identifier: NCT00193609 - Recruiting
  Neoplasms, Unknown Primary
  
• Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin
  ClinicalTrials.gov Identifier: NCT00004005 - Active, not recruiting
  adult solid tumor; carcinoma of unknown primary; childhood solid tumor; Colon Cancer; Rectal Cancer
  
• Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients with Carcinoma of Unknown Primary Site
  ClinicalTrials.gov Identifier: NCT00148135 - Recruiting
  Carcinoma of Unknown Primary Site (CUP)
  
• Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site
  ClinicalTrials.gov Identifier: NCT00193596 - Recruiting
  Neoplasms, Unknown Primary
  
• Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00004922 - Completed
  newly diagnosed carcinoma of unknown primary; Neuroendocrine Carcinoma; recurrent carcinoma of unknown primary; stage III Merkel cell carcinoma; ...
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer.
  ClinicalTrials.gov Identifier: NCT00003943 - Active, not recruiting
  extensive stage small cell lung cancer; newly diagnosed carcinoma of unknown primary
  
• Gemox as First and Second Line Therapy in Unknown Primary Cancer
  ClinicalTrials.gov Identifier: NCT00353145 - Active, not recruiting
  Unknown Primary Neoplasms
  
• Trial Comparing Cisplatin With or Without Gemcitabine in Patients with Carcinoma of Unknown Primary
  ClinicalTrials.gov Identifier: NCT00126269 - Recruiting
  Carcinoma
  
• PET-CT Scan as a Diagnostic Method in Unknown Primary Tumors
  ClinicalTrials.gov Identifier: NCT00269373 - Recruiting
  Unknown Primary Tumor
  
• Randomized Fase II Study: Cisplatin/Paclitaxel/Gemcitabine +/- Avastin in Patients With Unknown Primary Tumor
  ClinicalTrials.gov Identifier: NCT00458315 - Not yet recruiting
  Unknown Primary Tumors
  
• Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown Primary
  ClinicalTrials.gov Identifier: NCT00201734 - Recruiting
  Tumors; Unknown Primary Tumors; Adenocarcinoma
  
• Doxorubicin With or Without Chemoembolization in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)
  ClinicalTrials.gov Identifier: NCT00079027 - Active, not recruiting
  advanced adult primary liver cancer; adult primary hepatocellular carcinoma
  
• PET-CT for Squamous Cell Carcinoma (SCC) of the Neck Nodes Unknown Primary Malignancy
  ClinicalTrials.gov Identifier: NCT00530283 - Recruiting
  Squamous Cell Cancer
  
• TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)
  ClinicalTrials.gov Identifier: NCT00077142 - Active, not recruiting
  advanced adult primary liver cancer; recurrent adult primary liver cancer; adult primary hepatocellular carcinoma; ...
  
• Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer)
  ClinicalTrials.gov Identifier: NCT00077441 - Active, not recruiting
  adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized unresectable adult primary liver cancer; ...
  
• SCH 66336 With or Without Gemcitabine Followed by Surgery Compared With Surgery Alone in Treating Patients With Primary Liver Cancer
  ClinicalTrials.gov Identifier: NCT00020774 - Active, not recruiting
  recurrent adult primary liver cancer; localized resectable adult primary liver cancer; adult primary hepatocellular carcinoma; ...
  
• Epirubicin and Celecoxib in Treating Patients With Hepatocellular Carcinoma Cancer
  ClinicalTrials.gov Identifier: NCT00057980 - Active, not recruiting
  advanced adult primary liver cancer; localized unresectable adult primary liver cancer; adult primary hepatocellular carcinoma
  
• Gefitinib in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)
  ClinicalTrials.gov Identifier: NCT00071994 - Active, not recruiting
  advanced adult primary liver cancer; recurrent adult primary liver cancer; adult primary hepatocellular carcinoma; ...
  
• Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)
  ClinicalTrials.gov Identifier: NCT00047229 - Active, not recruiting
  adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized unresectable adult primary liver cancer; ...
  
• Doxorubicin and Bortezomib in Treating Patients With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00083226 - Active, not recruiting
  adult primary hepatocellular carcinoma; advanced adult primary liver cancer; recurrent adult primary liver cancer; ...
  
• Photodynamic Therapy in Treating Patients With Recurrent, Refractory, or Second Primary Head and Neck Cancer That Cannot Be Treated With Surgery or Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00003856 - Active, not recruiting
  recurrent squamous cell carcinoma of the oropharynx; recurrent squamous cell carcinoma of the hypopharynx; recurrent salivary gland cancer; ...
  
• Chemotherapy in Treating Patients With Unresectable Primary or Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00003714 - Active, not recruiting
  advanced adult primary liver cancer; liver metastases; adult primary hepatocellular carcinoma; localized unresectable adult primary liver cancer
  
• Gene Therapy in Treating Patients With Cancer of The Liver
  ClinicalTrials.gov Identifier: NCT00003147 - Active, not recruiting
  adult primary hepatocellular carcinoma; localized unresectable adult primary liver cancer
  
• Vaccine Therapy in Treating Patients With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00005629 - Active, not recruiting
  recurrent adult primary liver cancer; advanced adult primary liver cancer; localized resectable adult primary liver cancer; ...
  
• AZD2171 in Treating Patients With Locally Advanced or Metastatic Liver Cancer
  ClinicalTrials.gov Identifier: NCT00238394 - Active, not recruiting
  Adult Primary Hepatocellular Carcinoma; Advanced Adult Primary Liver Cancer; Localized Unresectable Adult Primary Liver Cancer
  
• Hepatic Arterial Chemoembolization With Cisplatin or Internal Radiation Therapy in Treating Patients With Advanced Liver Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00109954 - Active, not recruiting
  adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized unresectable adult primary liver cancer; ...
  
• Vaccine Therapy in Treating Patients With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00022334 - Active, not recruiting
  localized resectable adult primary liver cancer; localized unresectable adult primary liver cancer; advanced adult primary liver cancer; ...
  
• Megestrol in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00041275 - Active, not recruiting
  localized unresectable adult primary liver cancer; advanced adult primary liver cancer; adult primary hepatocellular carcinoma
  
• Radioactive Iodine in Treating Patients Who Have Undergone Surgery for Liver Cancer
  ClinicalTrials.gov Identifier: NCT00027768 - Active, not recruiting
  localized resectable adult primary liver cancer; adult primary hepatocellular carcinoma
  
• Bevacizumab in Treating Patients With Unresectable Nonmetastatic Liver Cancer
  ClinicalTrials.gov Identifier: NCT00055692 - Active, not recruiting
  adult primary hepatocellular carcinoma; recurrent adult primary liver cancer; localized unresectable adult primary liver cancer
  
• Positron Emission Tomography Using Carbon-11 Acetate and Fludeoxyglucose F 18 in Detecting Hepatocellular Carcinoma (Liver Cancer) in Patients With Known or Suspected Liver Cancer
  ClinicalTrials.gov Identifier: NCT00081094 - Active, not recruiting
  adult primary hepatocellular carcinoma; recurrent adult primary liver cancer; localized resectable adult primary liver cancer
  
• Doxorubicin and Interleukin-2 in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00004248 - Active, not recruiting
  recurrent adult primary liver cancer; adult primary hepatocellular carcinoma; localized unresectable adult primary liver cancer
  
• Radiation Therapy Following Surgery in Treating Patients With Recurrent or Second Primary Cancer of the Head and Neck Following Previous Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00004226 - Active, not recruiting
  recurrent squamous cell carcinoma of the lip and oral cavity; recurrent squamous cell carcinoma of the hypopharynx; ...
  
• Tamoxifen in Treating Patients With Primary Liver Cancer
  ClinicalTrials.gov Identifier: NCT00003424 - Active, not recruiting
  advanced adult primary liver cancer; adult primary hepatocellular carcinoma; localized unresectable adult primary liver cancer; Quality of Life
  
• Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis
  ClinicalTrials.gov Identifier: NCT00132041 - Active, not recruiting
  adult primary hepatocellular carcinoma; localized unresectable adult primary liver cancer
  
• T900607 in Treating Patients With Unresectable Liver Cancer
  ClinicalTrials.gov Identifier: NCT00054262 - Active, not recruiting
  localized unresectable adult primary liver cancer; advanced adult primary liver cancer; adult primary hepatocellular carcinoma
  
• Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver
  ClinicalTrials.gov Identifier: NCT00003907 - Active, not recruiting
  localized unresectable adult primary liver cancer; advanced adult primary liver cancer; recurrent adult primary liver cancer; ...
  
• Hepatic Arterial Infusion Plus Internal Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00039078 - Recruiting
  localized unresectable adult primary liver cancer; recurrent adult primary liver cancer; adult primary hepatocellular carcinoma
  
• Gene Therapy in Treating Patients With Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003257 - Active, not recruiting
  recurrent squamous cell carcinoma of the hypopharynx; recurrent squamous cell carcinoma of the larynx; ...
  
• Arsenic Trioxide in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00128596 - Recruiting
  adult primary hepatocellular carcinoma; advanced adult primary liver cancer; recurrent adult primary liver cancer
  
• Chemoembolization and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed With Surgery
  ClinicalTrials.gov Identifier: NCT00049322 - Recruiting
  localized unresectable adult primary liver cancer; recurrent adult primary liver cancer; adult primary hepatocellular carcinoma
  
• DX-8951f in Treating Patients With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00004108 - Active, not recruiting
  recurrent adult primary liver cancer; advanced adult primary liver cancer; localized resectable adult primary liver cancer; ...
  
• Sho-Saiko-To Following Removal of Liver Cancer By Embolization in Treating Patients With Liver Cancer That Cannot Be Surgically Removed
  ClinicalTrials.gov Identifier: NCT00040898 - Active, not recruiting
  localized unresectable adult primary liver cancer; advanced adult primary liver cancer; recurrent adult primary liver cancer; ...
  
• A Phase II Protocol of Arsenic Trioxide (Trisenox) in Subjects With Advanced Primary Carcinoma of the Liver
  ClinicalTrials.gov Identifier: NCT00582400 - Recruiting
  Carcinoma, Hepatocellular
  
• Efficacy of Å6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels
  ClinicalTrials.gov Identifier: NCT00083928 - Recruiting
  Ovarian Cancer; Primary Peritoneal Carcinoma
  
• Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer
  ClinicalTrials.gov Identifier: NCT00003296 - Active, not recruiting
  recurrent adult primary liver cancer; localized gallbladder cancer; advanced adult primary liver cancer; cholangiocarcinoma of the gallbladder; ...
  
• Oxaliplatin in Treating Patients With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00052364 - Active, not recruiting
  advanced adult primary liver cancer; localized unresectable adult primary liver cancer; recurrent adult primary liver cancer; ...
  
• Feasibility Study of Pazopanib in Combination With Chemo in Gyn Tumors
  ClinicalTrials.gov Identifier: NCT00561795 - Recruiting
  Epithelial Ovarian Cancer; Carcinoma; Uterine Disease; Tumor; Primary Peritoneal Carcinoma; Cervix Diseases
  
• Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
  ClinicalTrials.gov Identifier: NCT00006010 - Active, not recruiting
  localized unresectable adult primary liver cancer; advanced adult primary liver cancer; recurrent adult primary liver cancer; ...
  
• Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00113399 - Active, not recruiting
  recurrent squamous cell carcinoma of the hypopharynx; recurrent squamous cell carcinoma of the larynx; ...
  
• Active Immunization of Patients With Carcinoma of Oral Cavity or Oropharynx With Autologous Dendritic Cells Transfected With DNA From Autologous Tumor
  ClinicalTrials.gov Identifier: NCT00377247 - Recruiting
  Primary Advanced Carcinoma of the Oral Cavity or Oropharynx; Squamous Cell Carcinoma of the Head and Neck
  
• Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma
  ClinicalTrials.gov Identifier: NCT00582205 - Recruiting
  Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Carcinoma; Uterine Cancer
  
• Dose Escalation Study for Primary Hepatocellular Carcinoma
  ClinicalTrials.gov Identifier: NCT00243841 - Recruiting
  Carcinoma, Hepatocellular
  
• Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma
  ClinicalTrials.gov Identifier: NCT00183794 - Recruiting
  Ovarian Carcinoma; Peritoneal Neoplasms
  
• Radiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients with Primary Anal Cancer
  ClinicalTrials.gov Identifier: NCT00025090 - Recruiting
  Anal Cancer; basaloid carcinoma of the anus; cloacogenic carcinoma of the anus; squamous cell carcinoma of the anus
  
• Topotecan Plus Paclitaxel and Carboplatin in the Initial Treatment of Advanced Ovarian and Primary Peritoneal Carcinoma
  ClinicalTrials.gov Identifier: NCT00193297 - Active, not recruiting
  Ovary Cancer
  
• Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00511992 - Recruiting
  Advanced Ovarian Carcinoma; Primary Peritoneal Carcinoma; Ovarian Carcinosarcoma
  
• Prospective Randomised Study of Doxorubicin in the Treatment of Hepatocellular Carcinoma by Drug-Eluting Bead Embolisation (PRECISION V)
  ClinicalTrials.gov Identifier: NCT00261378 - Active, not recruiting
  Primary Liver Cancer
  
• A Study of Recombinant Vaccinia Virus to Treat Unresectable Primary Hepatocellular Carcinoma
  ClinicalTrials.gov Identifier: NCT00554372 - Not yet recruiting
  Carcinoma, Hepatocellular
  
• Phase III Study of PI-88 in Post-Resection Hepatocellular Carcinoma
  ClinicalTrials.gov Identifier: NCT00568308 - Recruiting
  Cancer; Liver Cancer; Primary Liver Cancer; Hepatocellular Carcinoma; Hepatoma
  
• Phase II Study of Modified Triple Doublet Therapy in Women with Newly Diagnosed Mullerian Carcinoma
  ClinicalTrials.gov Identifier: NCT00157560 - Active, not recruiting
  Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer
  
• Cisplatin Plus Epinephrine in Treating Patients With Recurrent or Refractory Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00002659 - Active, not recruiting
  recurrent squamous cell carcinoma of the hypopharynx; recurrent squamous cell carcinoma of the larynx; ...
  
• Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer
  ClinicalTrials.gov Identifier: NCT00003557 - Active, not recruiting
  recurrent adult primary liver cancer; advanced adult primary liver cancer; cholangiocarcinoma of the gallbladder; ...
  
• Dosimetric Analysis of Vaginal Cuff Brachytherapy in Endometrial Carcinoma
  ClinicalTrials.gov Identifier: NCT00165126 - Active, not recruiting
  Endometrial Carcinoma; Cervix Cancer; Carcinoma of the Uterus
  
• Phase II Clinical Study of Pegylated Liposomal Doxorubicin Hydrochloride Injection as 2nd-Line or Later Therapy in Patients With Müllerian Carcinoma (Epithelial Ovarian Carcinoma, Primary Carcinoma of Fallopian Tube, Peritoneal Carcinoma) Having Prior Pl
  ClinicalTrials.gov Identifier: NCT00216645 - Completed
  Ovarian Neoplasms
  
• BAY 43-9006 in Treating Patients With Advanced Inoperable Liver Cancer
  ClinicalTrials.gov Identifier: NCT00058383 - No longer recruiting
  adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized unresectable adult primary liver cancer
  
• Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
  ClinicalTrials.gov Identifier: NCT00059865 - Active, not recruiting
  advanced adult primary liver cancer; unresectable gallbladder cancer; unresectable extrahepatic bile duct cancer; ...
  
• A Research Study to Treat Patients with Advanced Hepatocellular Carcinoma
  ClinicalTrials.gov Identifier: NCT00105443 - Active, not recruiting
  Hepatocellular Carcinoma
  
• Capecitabine in Women with Operable Breast Cancer
  ClinicalTrials.gov Identifier: NCT00148720 - Active, not recruiting
  Invasive Breast Carcinoma; Primary Invasive Breast Cancer; stage I breast cancer; Stage II Breast Cancer; Stage III Breast Cancer
  
• Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer
  ClinicalTrials.gov Identifier: NCT00002506 - Active, not recruiting
  recurrent non-small cell lung cancer; recurrent cervical cancer; recurrent squamous cell carcinoma of the lip and oral cavity; ...
  
• Patupilone Activity in Advanced/Metastatic Hepatocelluar Carcinoma
  ClinicalTrials.gov Identifier: NCT00273312 - Active, not recruiting
  Hepatocellular Carcinoma
  
• Radiation Therapy Plus Fludarabine in Treating Patients With Locally Advanced Cancer of the Mouth, Pharynx, or Larynx
  ClinicalTrials.gov Identifier: NCT00004246 - Active, not recruiting
  stage IV squamous cell carcinoma of the lip and oral cavity; stage IVA squamous cell carcinoma of the nasopharynx; ...
  
• Epirubicin and Thalidomide in Treating Patients With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00058487 - Completed
  adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized unresectable adult primary liver cancer; ...
  
• RAD001 plus Depot Octreotide in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma
  ClinicalTrials.gov Identifier: NCT00113360 - Active, not recruiting
  Carcinoma, Neuroendocrine; Carcinoid Tumor; Carcinoma, Islet Cell
  
• Cetuximab in Patients with Unresectable or Metastatic Hepatocellular Carcinoma
  ClinicalTrials.gov Identifier: NCT00142428 - Active, not recruiting
  Unresectable hepatocellular carcinoma; Metastatic hepatocellular carcinoma; Hepatocellular Carcinoma
  
• Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer That Has Been Removed During Surgery
  ClinicalTrials.gov Identifier: NCT00002670 - Active, not recruiting
  stage IV squamous cell carcinoma of the lip and oral cavity; stage II squamous cell carcinoma of the lip and oral cavity; ...
  
• High-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00002555 - Active, not recruiting
  stage III squamous cell carcinoma of the lip and oral cavity; stage IV squamous cell carcinoma of the lip and oral cavity; ...
  
• Thalidomide and Chemoembolization With Doxorubicin in Treating Patients With Liver Cancer That Cannot be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00006016 - Completed
  localized unresectable adult primary liver cancer; advanced adult primary liver cancer; adult primary hepatocellular carcinoma
  
• Trial of Tri-Weekly TJ Versus Weekly TJ for Stage II-IV Mullerian Carcinoma
  ClinicalTrials.gov Identifier: NCT00226915 - Active, not recruiting
  Epithelial Ovarian Cancer; Primary Peritoneal Cancer; Fallopian Tube Cancer
  
• Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases
  ClinicalTrials.gov Identifier: NCT00019786 - Active, not recruiting
  Colorectal Cancer; Islet Cell Tumor; Liver Cancer; Metastatic Cancer; Neuroendocrine Carcinoma
  
• Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver Tumors
  ClinicalTrials.gov Identifier: NCT00493883 - Recruiting
  Carcinoma, Hepatocellular; Liver Neoplasms
  
• ZD6474 With Radiation or Concomitantly With Weekly Cisplatin and Radiation Therapy, Stage III-IV Head and Neck Squamous Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00411710 - Recruiting
  Head and Neck Squamous Cell Carcinoma; Squamous Cell Carcinoma of the Oral Cavity; Squamous Cell Carcinoma of the Oropharynx; Squamous Cell Carcinoma of the Hypopharynx; Squamous Cell Carcinoma of the Larynx
  
• A Study of Motexafin Gadolinium (MGd) in Combination with Docetaxel and Cisplatin for Treatment of Non-Small Cell Lung Cancer (NSCLC)
  ClinicalTrials.gov Identifier: NCT00102505 - Active, not recruiting
  Non-Small-Cell Lung Carcinoma; Carcinoma, Bronchogenic
  
• Erlotinib in Treating Patients With Liver Cancer That Cannot be Surgically Removed
  ClinicalTrials.gov Identifier: NCT00047333 - Completed
  adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized unresectable adult primary liver cancer
  
• A Study of ThermoDox™ in Combination With Radiofrequency Ablation (RFA) in Primary and Metastatic Tumors of the Liver
  ClinicalTrials.gov Identifier: NCT00441376 - Recruiting
  Hepatocellular Carcinoma; Liver Neoplasms
  
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00054054 - Active, not recruiting
  stage III squamous cell carcinoma of the hypopharynx; stage III squamous cell carcinoma of the larynx; ...
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003888 - Active, not recruiting
  stage IV squamous cell carcinoma of the lip and oral cavity; stage III squamous cell carcinoma of the hypopharynx; ...
  
• Phase 2b Study of VELCADE Alone and VELCADE plus Irinotecan in Patients with Relapsed or Refractory Colorectal Carcinoma
  ClinicalTrials.gov Identifier: NCT00051987 - Active, not recruiting
  Colorectal Carcinoma
  
• A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck Cancers
  ClinicalTrials.gov Identifier: NCT00122239 - Recruiting
  -breast carcinoma; -glioma; -prostate carcinoma; -squamous cell carcinoma of the head and neck; -lung carcinoma (non-small cell)
  
• Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00005814 - Active, not recruiting
  stage III squamous cell carcinoma of the paranasal sinus and nasal cavity; stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity; ...